NPS Pharmaceuticals, Inc. (NASDAQ:NPSP.DL)

CAPS Rating: No stars

A biopharmaceutical company focused on the development and commercialization of small molecule drugs and recombinant proteins.

NPSP.DL News and Commentary

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NPSP.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

muksdotca (< 20)
Submitted March 21, 2008

When everyone was watching BSC and the sky falling NSPS reported positive top-line results from a 28-week blinded Phase 3-extension study of GATTEX(TM) to deaf ears.NPS Reports Successful GATTEX(TM) Extension… More

synergize (29.08)
Submitted June 09, 2008

NPS Pharmaceuticals, Inc. (NPS) is a biopharmaceutical company engaged in the development of specialty therapeutics to treat gastrointestinal (GI) and endocrine disorders with unmet medical need. As of April 15, 2008, the Company was advancing two… More

NPSP.DL VS S&P 500 (SPY)

NPSP.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about NPSP.DL.

No one has written a Pitch for NPSP.DL stock yet. Tell us why you think NPSP.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in NPSP.DL.

No players have picked NPSP.DL yet. Tell us why you think NPSP.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 85.44 2/4/2015 Underperform 3W $45.89 +0.17% +3.52% +3.34 2/23/2015 @ $45.97 0 Comment
TrackJanney 87.76 5/22/2014 Outperform NS $26.44 +73.87% +11.66% +62.21 2/23/2015 @ $45.97 0 Comment
TrackJimCramer 85.44 11/6/2013 Outperform 3W $23.79 +92.90% +15.18% +77.72 2/4/2015 @ $45.89 0 Comment
TrackJimCramer 85.44 10/10/2013 Underperform 3W $33.15 -28.24% +4.73% +32.96 11/6/2013 @ $23.79 0 Comment
TrackBofASec 92.21 10/3/2013 Outperform NS $34.48 +33.32% +25.15% +8.17 2/23/2015 @ $45.97 0 Comment
TrackJPMorgan 86.98 9/20/2013 Outperform NS $29.65 +55.04% +22.58% +32.46 2/23/2015 @ $45.97 0 Comment
TrackOppenheimer 73.69 4/24/2013 Outperform NS $13.45 +241.78% +33.84% +207.94 2/23/2015 @ $45.97 0 Comment
TrackJimCramer 85.44 10/24/2012 Outperform 3W $9.16 +261.90% +19.96% +241.94 10/10/2013 @ $33.15 0 Comment
TrackJimCramer 85.44 10/12/2012 Underperform 3W $10.86 -15.65% -1.31% +14.35 10/25/2012 @ $9.16 0 Comment
TrackJimCramer 85.44 9/18/2012 Outperform 3W $8.24 +31.80% -2.54% +34.34 10/12/2012 @ $10.86 0 Comment
TrackCanaccord 63.72 5/7/2012 Outperform NS $7.16 +542.04% +54.74% +487.30 2/23/2015 @ $45.97 0 Comment
TrackStifel 92.10 10/5/2011 Outperform NS $6.58 +598.63% +87.57% +511.06 2/23/2015 @ $45.97 0 Comment
trackthinkequity 89.84 6/2/2010 Outperform NS $6.80 +576.03% +93.80% +482.23 2/23/2015 @ $45.97 0 Comment
TrackNeedham 90.63 4/7/2010 Outperform NS $5.27 +77.80% +11.84% +65.96 3/31/2011 @ $9.37 0 Comment
TrackBreanMurray 73.21 6/11/2009 Outperform NS $4.30 +969.07% +123.34% +845.73 2/23/2015 @ $45.97 0 Comment
TrackPiperJaff 85.40 3/27/2009 Outperform NS $4.58 +903.71% +157.45% +746.26 2/23/2015 @ $45.97 0 Comment
TrackJefferies 79.73 3/16/2009 Outperform NS $4.72 +873.94% +174.48% +699.46 2/23/2015 @ $45.97 0 Comment
TrackSoros 87.46 10/2/2007 Outperform NS $5.58 +723.84% +37.09% +686.75 2/23/2015 @ $45.97 1 Comment
TrackOppenheimer 73.69 9/12/2007 Outperform NS $4.55 -11.65% +5.54% -17.19 10/12/2007 @ $4.02 0 Comment

Featured Broker Partners


Advertisement